Echosens

Echosens Empowering medical professionals to assess, diagnose
and manage chronic liver diseases, everywhere,
f The examination is non-invasive, fast, and painless.

Echosens™, founded in 2001, is a French high-technology company specialising in non-invasive diagnostics for use in hepatology. Echosens™ is very active in research and development, and currently holds patents from 17 different fields, focusing mainly on its key technology: Vibration-Controlled Transient Elastography (VCTE™). n innovative technology: Vibration-Controlled Transient Elastography (VCTE)

Echosens™ is the inventor of a highly innovative technology: pulse elastography. This has caused a fundamental change in the clinical practice of hepatologists. Echosens develops and markets the FibroScan®, a unique device for the diagnosis and monitoring of liver disease. With more than 660 publications, FibroScan® with its dedicated probes is the elastography device with by far the most evidence to demonstrate its clinical usefulness. The best-performing range of blood tests on the market

Applying the same philosophy, FibroMeter™ scores combine several biological markers to predict the presence of fibrosis in the liver. This complete range of blood scores, developed by Prof. Calès's team at the Angers teaching hospital in France, has given rise to the publication of many articles in world-class scientific journals, and is covered by a series of patents. Echosens™ devotes a significant proportion of its activity to research, with the aim of developing new medical devices and opening up new medical horizons. The company works in close collaboration with health professionals and patients' associations to facilitate the therapeutic monitoring of patients. To date, more than 2000 FibroScan® units have been installed all over the world. Structure

🌍 On this World Diabetes Day, let’s talk about the liver.Did you know that Type 2 Diabetes (T2D) is a major risk factor ...
14/11/2025

🌍 On this World Diabetes Day, let’s talk about the liver.
Did you know that Type 2 Diabetes (T2D) is a major risk factor for MASLD (Metabolic dysfunction-associated steatotic liver disease), the most common chronic liver disease globally?

🔎 The numbers are striking:
🔹76% of people with T2D have MASLD
🔹18% already show signs of advanced liver fibrosis or cirrhosis

If left undiagnosed, MASLD can silently progress to irreversible damage like cirrhosis or liver cancer. An examination with FibroScan® can help diagnose these diseases early and non-invasively.

💡 This World Diabetes Day, let’s raise awareness about this critical link and empower individuals with knowledge. Early detection and informed lifestyle choices can make a profound difference in health outcomes.
Learn more about diabetes 👉 https://worlddiabetesday.org/
Learn more about liver health 👉 https://www.echosens.com/liver-health/

What an incredible week at  ! 🙏 Thank you to everyone who stopped by our booth to learn how FibroScan® powered by Guided...
12/11/2025

What an incredible week at ! 🙏

Thank you to everyone who stopped by our booth to learn how FibroScan® powered by Guided VCTE™ and the LHM Platform are transforming liver care.

From early detection to connected management, we’re proud to advance innovation that empowers liver specialists and patients worldwide.

💙 See some of our favorite moments from the show below!

🌍 At  , Echosens is showcasing the power of Guided VCTE™ and the LHM Platform—a seamless combination of validated precis...
10/11/2025

🌍 At , Echosens is showcasing the power of Guided VCTE™ and the LHM Platform—a seamless combination of validated precision and digital insight.

Together, they empower clinicians to manage liver disease with confidence and speed.

✅ Validated. Proven. Exclusively FibroScan®.

Because when it comes to metabolic disease, every data point matters.

  attendees—are you ready to streamline your liver health management workflow?  Stop by Echosens’ BOOTH  #525 to see how...
09/11/2025

attendees—are you ready to streamline your liver health management workflow?

Stop by Echosens’ BOOTH #525 to see how the FibroScan® experience is smarter than ever with the LHM platform, an ecosystem for continuous monitoring and proactive management of liver disease.

💻 Automatically transfer FibroScan® results for data-driven decisions
🌐 Enable remote interpretation and synchronized worklists
🧩 Integrate scores and biological markers for clearer insights

Come say hello and see how the LHM platform transforms practice efficiency in real time!

Live from  ! Experience FibroScan® powered by Guided VCTE™—the next generation of speed, precision, and consistency in l...
08/11/2025

Live from ! Experience FibroScan® powered by Guided VCTE™—the next generation of speed, precision, and consistency in liver assessment—at Echosens’ BOOTH #525.

⚡Complete exams faster: 96% finished in under 4 minutes (even in patients with BMI >30)
🎯 Real-time visual targeting: Exclusive visual indicators guide optimal placement for liver stiffness and CAP™ measurements
🧭 AutoScan technology: Automatically captures 10 valid measurements with one click
🧩 Consistency built in: Strict design controls minimize operator variability
🏥 Ready for real-world care: Seamless integration with minimal learning curve

With its speed, simplicity, and scalability, FibroScan® powered by Guided VCTE™ is an essential tool for every liver specialist. Come see why! 👋

✨️ New Liver Health Shaper podcast episode out now! ✨Dr. Angelo Paredes, a leading gastroenterologist and hepatologist, ...
06/11/2025

✨️ New Liver Health Shaper podcast episode out now! ✨

Dr. Angelo Paredes, a leading gastroenterologist and hepatologist, shares how digital innovation is transforming MASLD and MASH care.
Using FibroScan® and LHM Connect, a cloud-based platform, he shows how healthcare providers can:

✅ Integrate data seamlessly into workflows
✅ Motivate patients to better understand and manage their liver health
✅ Collaborate securely across care teams
The impact of LHM Connect comes to life through a powerful patient story where detection of advanced fibrosis led to life-changing care.
🎧 Listen now: https://smartlink.ausha.co/liver-health-shaper/advancing-liver-health-management-through-digital-integration-with-lhm-connect

In the fourth episode of Liver Health Shaper, host Tenley Hart takes us beyond diagnostics and into the next frontier of digital liver care: LHM Connect, Echosens’ innovative cloud-based platform that seamlessly links FibroScan® results with clinical insights. Our guest, Dr. Angelo Paredes, gastr...

Metabolic conditions—including MASLD and MASH—are rising fast. Diagnosis and management need to move faster.  At  , Echo...
05/11/2025

Metabolic conditions—including MASLD and MASH—are rising fast. Diagnosis and management need to move faster.

At , Echosens will showcase how innovation is meeting that challenge. From Guided VCTE™—our next-generation advancement in speed, precision, and consistency for liver health assessment—to the LHM Platform, a digital ecosystem that streamlines workflows and supports clinical decisions, we’re empowering care teams to transform metabolic care.

📍Visit us at BOOTH #525 to see how precision and digital intelligence are advancing liver care faster than ever before.

📈 Employers: Are you ready to see better health outcomes and reduce costs? It's time to build a truly comprehensive meta...
03/11/2025

📈 Employers: Are you ready to see better health outcomes and reduce costs? It's time to build a truly comprehensive metabolic health program that tackles the often-overlooked link between steatotic liver disease and cardiometabolic health.

Whole-person health is the foundation of a thriving workforce. For benefits leaders, that means going beyond fragmented care with a strategy that covers every step:
➡️Identify and engage those at risk
➡️Screen the liver
➡️Stratify risk
➡️Develop a care plan
➡️Monitor progress

🔑 By embracing a holistic strategy, employers can unlock a multi-faceted value proposition: healthier employees, greater productivity, lower costs, and stronger retention.

📣 We are proud to announce the opening of our new offices in India! This expansion reflects our desire to get closer to ...
30/10/2025

📣 We are proud to announce the opening of our new offices in India! This expansion reflects our desire to get closer to our customers and partners around the world.

📍The new office, located in the Bandra Kurla Complex (BKC) in Mumbai, will serve as a hub for operations in South Asia, thereby expanding access to FibroScan®.
Our Mumbai headquarters will oversee regional sales operations, including the sale of FibroScan® devices and the management of relationships with our local business partners. The site will also serve as a training and education center.

🙏 A huge thank you to all the teams who helped make this project possible and to all the healthcare professionals who place their trust in us every day.

🙌 Thank you to everyone who stopped by Echosens’ booth at  ! It was inspiring to connect with so many gastroenterologist...
29/10/2025

🙌 Thank you to everyone who stopped by Echosens’ booth at !

It was inspiring to connect with so many gastroenterologists and partners leading the way in metabolic and liver health.

From early detection to multidisciplinary collaboration, we’re so proud to see FibroScan® helping providers translate liver insights into meaningful action for patients.

Until next time—keep leading the change in liver health. 💙

Health

🫱🏼‍🫲🏽Gastroenterologists don’t work in silos—and neither does the liver.💡At  , Echosens is highlighting how FibroScan® s...
27/10/2025

🫱🏼‍🫲🏽Gastroenterologists don’t work in silos—and neither does the liver.

💡At , Echosens is highlighting how FibroScan® supports collaboration across specialties. When gastroenterologists, hepatologists, endocrinologists, and primary care providers work together and share objective liver data, they can detect MASLD and MASH earlier, coordinate care, and prevent disease progression.

📍Stop by BOOTH 820 to learn how FibroScan® enables more connected care for steatotic liver disease and metabolic dysfunction.

Health

🌟 At  , Echosens is highlighting how gastroenterologists can transform metabolic health with liver care.  📈 FibroScan® t...
26/10/2025

🌟 At , Echosens is highlighting how gastroenterologists can transform metabolic health with liver care.

📈 FibroScan® turns invisible risk into visible motivation for patients. When they see quantifiable proof of liver fat or fibrosis, it has the power to change the conversation—and their behavior.

👋 Stop by Echosens’ BOOTH 820, and let’s chat about how objective liver data can drive patient engagement and better outcomes.

Health

Adresse

6 Rue Ferrus
Paris
75014

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Echosens publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter La Pratique

Envoyer un message à Echosens:

Partager

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type

Our Story

In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan, the unique device using patented and validated VCTE™ for liver stiffness assessment, and CAP™ for steatosis quantification.

FibroScan device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,000 medical publications and 40 guidelines recommendations.

We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.